The medical treatment of fibroadentomas is still not well understood, and the most effective treatment, according to a study released Monday, is a multidisciplinary approach to treatment.
The study was done by the University of Texas Health Science Center at San Antonio.
It examined the effectiveness of a combination of surgery and radiation treatments for patients with fibroadenic tumors.
“It’s not just about a single therapy, but there’s a whole multidiscipline approach to how you treat fibroadencepsis,” said Dr. Scott Schoenfeld, professor of radiology at UT Health Science and Technology and one of the study’s authors.
The treatment, which is used to treat other types of tumors as well, involves both surgical and radiation procedures.
“You can’t just go to the hospital and have surgery,” Schoenfeld said.
“We have to think about how we treat this and how to make it safe.”
In the study, patients with 10 or more fibroadenteromas were treated with a combination therapy called interferon-alpha, which targets a protein in the tumors.
The drug is used for other types, such as glioma.
It is also used to stop blood clots in the body.
In the future, the treatment could be used for patients who have multiple tumors.
Schoenfld said the treatment can also be used to prevent the progression of the tumors and treat the cancer itself.
“You can treat the tumors by surgically removing them and by getting chemotherapy and radiotherapy to treat them, and by treating the disease itself,” he said.
Researchers at UTHS and the University at Buffalo also found that, for patients that were treated on their own, the risk of death from the disease was lower.
Schenfeld said he and his colleagues were concerned about the possibility of an increase in cancer deaths from the use of this type of therapy, and that the study was designed to look at the effects on the cancer patient.
“The data that we’ve gathered is so encouraging, but we need to continue to do studies to really understand the effects of this drug,” Schreng said.